Hansa Biopharma appoints Maria Törnsén as Chief Operating Officer and President U.S.

Chief Operating Officer (COO)/ Deputy Managing Director (DMD) BUBL At BRAC

The COO/DMD will support the Managing Director (MD) in providing overall strategic leadership and driving execution to achieve BUBL’s sustainable growth. This role oversees Banking Operations, Information Technology, Procurement, Compliance & Anti-Money Laundering, and Marketing & Communications, ensuring that all functions operate efficiently and effectively in alignment with the institution’s financial and social objectives. Strategic Leadersh…

Hansa Biopharma appoints Maria Törnsén as Chief Operating Officer and President U.S.

LUND, Sweden, May 13, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that Maria Törnsén has been appointed Chief Operating Officer (COO) and President U.S. effective 19 May. Ms Törnsén will report to CEO Renée Aguiar-Lucander…